Hdt Bio
HDT Bio is a biotechnology company developing drugs for cancer and infectious-disease immunotherapy.
- Headquarters
- Seattle, Washington, United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 51 to 200Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2018Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 13 supported appearances ↗Source: RevenueBase lists
What does Hdt Bio do?
The company is developing multiple product candidates from proprietary discovery platforms, including LION™. Its technologies are designed to access, activate, and amplify the immune system’s ability to create antibodies and T-cells against cancer and infectious diseases.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 5, 2026, September 15, 2026, September 18, 2026, September 19, 2026 and September 21, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.